Volume 33

Liver

Volume 33
4

Corrigendum

Year:
2013
File:
PDF, 70 KB
2013
7

Liver involvement in Turner syndrome

Year:
2013
Language:
english
File:
PDF, 295 KB
english, 2013
8

A major new step in non-invasive evaluation of portal hypertension: elastography

Year:
2013
Language:
english
File:
PDF, 98 KB
english, 2013
13

Oncogenic potential of Cyclin Kinase Subunit-2 in cholangiocarcinoma

Year:
2013
Language:
english
File:
PDF, 865 KB
english, 2013
14

Risk factors for porphyria cutanea tarda -the iron/HFE connection

Year:
2013
Language:
english
File:
PDF, 84 KB
english, 2013
23

Hepato-protective effects of alpha lipoic acid besides its role in preventing fatty liver disease

Year:
2013
Language:
english
File:
PDF, 88 KB
english, 2013
38

How to optimize HCV therapy in genotype 1 patients: predictors of response

Year:
2013
Language:
english
File:
PDF, 173 KB
english, 2013
39

Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?

Year:
2013
Language:
english
File:
PDF, 121 KB
english, 2013
40

Management of HBV in immunocompromised patients

Year:
2013
Language:
english
File:
PDF, 280 KB
english, 2013
41

How to optimize HCV therapy in genotype 2 patients

Year:
2013
Language:
english
File:
PDF, 152 KB
english, 2013
42

Impact of therapy on the outcome of chronic hepatitis B

Year:
2013
Language:
english
File:
PDF, 119 KB
english, 2013
43

Current management of delta hepatitis

Year:
2013
Language:
english
File:
PDF, 138 KB
english, 2013
44

How to optimize HCV therapy in genotype 4 patients

Year:
2013
Language:
english
File:
PDF, 124 KB
english, 2013
45

Optimal management of HBV infection during pregnancy

Year:
2013
Language:
english
File:
PDF, 189 KB
english, 2013
46

New therapeutic strategies in HCV: second-generation protease inhibitors

Year:
2013
Language:
english
File:
PDF, 116 KB
english, 2013
47

Current management and perspectives for HCV recurrence after liver transplantation

Year:
2013
Language:
english
File:
PDF, 276 KB
english, 2013
48

Best strategies for global HCV eradication

Year:
2013
Language:
english
File:
PDF, 170 KB
english, 2013
49

Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?

Year:
2013
Language:
english
File:
PDF, 295 KB
english, 2013
50

Why do I treat HBeAg-positive chronic hepatitis B patients with a Nucleoside analogue

Year:
2013
Language:
english
File:
PDF, 116 KB
english, 2013
51

Patients with HCV and F1 and F2 fibrosis stage: treat now or wait?

Year:
2013
Language:
english
File:
PDF, 133 KB
english, 2013
53

New therapeutic strategies in HCV: polymerase inhibitors

Year:
2013
Language:
english
File:
PDF, 199 KB
english, 2013
55

Optimal treatment with boceprevir for chronic HCV infection

Year:
2013
Language:
english
File:
PDF, 213 KB
english, 2013
56

The importance of IL28B genotype in hepatitis C virus-associated liver transplantation

Year:
2013
Language:
english
File:
PDF, 97 KB
english, 2013
57

Treatment of HBV related cirrhosis

Year:
2013
Language:
english
File:
PDF, 190 KB
english, 2013
59

Interferon free therapy with direct acting antivirals for HCV

Year:
2013
Language:
english
File:
PDF, 661 KB
english, 2013
60

Hope for the eradication of HCV worldwide

Year:
2013
Language:
english
File:
PDF, 97 KB
english, 2013
61

Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues

Year:
2013
Language:
english
File:
PDF, 199 KB
english, 2013
62

Optimal treatment with telaprevir for chronic HCV infection

Year:
2013
Language:
english
File:
PDF, 218 KB
english, 2013
64

Management of acute hepatitis B and reactivation of hepatitis B

Year:
2013
Language:
english
File:
PDF, 181 KB
english, 2013
65

HCV therapy in HIV-infected patients

Year:
2013
Language:
english
File:
PDF, 125 KB
english, 2013
66

Gens Una Sumus - still

Year:
2013
Language:
english
File:
PDF, 82 KB
english, 2013
67

An exciting time for Hepatology

Year:
2013
Language:
english
File:
PDF, 88 KB
english, 2013
68

Treatment of viral hepatitis: a new era

Year:
2013
Language:
english
File:
PDF, 92 KB
english, 2013
85

All beta-blockers are created equal, but some beta-blockers are more equal than others

Year:
2013
Language:
english
File:
PDF, 95 KB
english, 2013
89

The role of mTOR inhibitors in the treatment of hepatocellular carcinoma

Year:
2013
Language:
english
File:
PDF, 87 KB
english, 2013
92

Status of research on vitamin D supplementation in treating or preventing liver fibrosis

Year:
2013
Language:
english
File:
PDF, 104 KB
english, 2013
105

Corrigendum

Year:
2013
Language:
english
File:
PDF, 77 KB
english, 2013
106

Erratum

Year:
2013
Language:
english
File:
PDF, 77 KB
english, 2013
110

Atypical liver lesion in previous trauma: Magnetic Resonance appearance

Year:
2013
Language:
english
File:
PDF, 156 KB
english, 2013
113

An alternative treatment for muscle cramps in patients with liver cirrhosis

Year:
2013
Language:
english
File:
PDF, 135 KB
english, 2013
119

Vitamin D in chronic liver disease

Year:
2013
Language:
english
File:
PDF, 406 KB
english, 2013
124

Inguinal hernia - A possible pitfall in diagnosing ascites

Year:
2013
Language:
english
File:
PDF, 78 KB
english, 2013
135

Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis

Year:
2013
Language:
english
File:
PDF, 524 KB
english, 2013
136

Liver tissue engineering and cell sources: issues and challenges

Year:
2013
Language:
english
File:
PDF, 163 KB
english, 2013
145

On the role of intestinal hyperpermeability in complications of cirrhosis

Year:
2013
Language:
english
File:
PDF, 88 KB
english, 2013
147

Corrigendum

Year:
2013
File:
PDF, 72 KB
2013
154

Unusual presentations of spider angiomas

Year:
2013
Language:
english
File:
PDF, 155 KB
english, 2013